Baird Financial Group Inc. Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company’s stock after selling 5,494 shares during […]
Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company’s stock after selling 5,494 shares during […]
